Cite
Merkel R, Moreno A, Zhang Y, et al. A novel approach to treating opioid use disorders: Dual agonists of glucagon-like peptide-1 receptors and neuropeptide Y. Neurosci Biobehav Rev. 2021;131:1169-1179doi: 10.1016/j.neubiorev.2021.10.026.
Merkel, R., Moreno, A., Zhang, Y., Herman, R., Ben Nathan, J., Zeb, S., Rahematpura, S., Stecyk, K., Milliken, B. T., Hayes, M. R., Doyle, R. P., & Schmidt, H. D. (2021). A novel approach to treating opioid use disorders: Dual agonists of glucagon-like peptide-1 receptors and neuropeptide Y. Neuroscience and biobehavioral reviews, 1311169-1179. https://doi.org/10.1016/j.neubiorev.2021.10.026
Merkel, Riley, et al. "A novel approach to treating opioid use disorders: Dual agonists of glucagon-like peptide-1 receptors and neuropeptide Y." Neuroscience and biobehavioral reviews vol. 131 (2021): 1169-1179. doi: https://doi.org/10.1016/j.neubiorev.2021.10.026
Merkel R, Moreno A, Zhang Y, Herman R, Ben Nathan J, Zeb S, Rahematpura S, Stecyk K, Milliken BT, Hayes MR, Doyle RP, Schmidt HD. A novel approach to treating opioid use disorders: Dual agonists of glucagon-like peptide-1 receptors and neuropeptide Y. Neurosci Biobehav Rev. 2021 Dec;131:1169-1179. doi: 10.1016/j.neubiorev.2021.10.026. Epub 2021 Oct 29. PMID: 34715149; PMCID: PMC8642311.
Copy
Download .nbib